Going the distance: Delivery through the cell and gene Green Corridor

Advanced medicines like cell and gene therapies (CGTs) require rigorously controlled environments and short transport timelines. Logistical difficulties when delivering CGTs risk damaging the treatment and rendering it unusable, with significant negative effects on patients.

With mission-critical material in transit, extensive delays are the last thing you need. Our specialist customs brokerage team plans for every regulatory contingency based on unmatched local regulatory expertise.

By mobilizing our global network of World Courier associates and on-the-ground knowledge, we took advantage of India’s Green Corridor initiative to deliver a life-saving therapy.